Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.45
0.25 (1.24%)
At close: Aug 15, 2025, 10:05 AM

Neurogene Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.34 -6.84 -2.37 -105.03
PEG Ratio
-0.1 0.20 -0.01 -2.4
PS Ratio
434.14 n/a n/a n/a
PB Ratio
1.29 1.34 -0.9 -57.75
P/FCF Ratio
-5.62 -4.8 -2.37 -81.92
P/OCF Ratio
-5.69 -4.83 -2.47 -114.35
OCF/S Ratio
-76.33 n/a n/a n/a
Debt / Equity Ratio
0.04 0.09 -0.03 -0.06
Quick Ratio
20.84 8.72 12.58 6.64
Current Ratio
20.84 8.72 12.74 6.81
Asset Turnover
0.00 n/a n/a n/a
Interest Coverage
-6.88K -4.63K -28.26K n/a
Return on Equity
-0.24 -0.2 0.38 0.55
Return on Assets
-0.22 -0.16 -0.51 -0.5
Return on Invested Capital
-0.26 -0.27 -0.55 -0.55
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
-2.51 n/a n/a n/a
Net Profit Margin
-81.24 n/a n/a n/a
Pretax Profit Margin
-81.24 n/a n/a n/a
Operating Profit Margin
-89.3 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-77.71 n/a n/a n/a